Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Astrazeneca Plc (AZN)

2014-12-19@08:58:29 ET
Potential AstraZeneca (AZN) Trade Targets 3.23% Return (FBM)

2014-12-18@13:56:49 ET
Shares of AstraZeneca Receive a Boost, Up 2.7% (F77)

2014-12-18@04:24:53 ET
Malaria - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:32 ET
Metastatic Melanoma - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:08:11 ET
Myelofibrosis - Pipeline Review, H1 2014 (MTO)

2014-12-16@09:29:24 ET
Global Oncology Market - Trends, Forecast and Pipeline Analysis 2014-2020 - Market is Poised to Grow to $109 Billion by 2020 (MTO)

2014-12-15@15:37:26 ET
AstraZeneca (AZN) Showing Bearish Technicals With Resistance At $73.94 (FBM)

2014-12-15@14:49:46 ET
Shares of AstraZeneca Are Moving Lower on 1.3x Above-Average Volume (AZN) (F82)

2014-12-15@12:45:50 ET
AstraZeneca Shares Sinking Lower, Down 2.2% (F77)

2014-12-15@09:15:07 ET
AstraZeneca receives marketing authorization from EC for OIC drug (DTM)

2014-12-15@04:39:34 ET
Ewing Sarcoma - Pipeline Review, H1 2014 (MTO)

2014-12-15@04:28:52 ET
Haemophilus Influenzae Infections - Pipeline Review, H2 2013 (MTO)

2014-12-15@04:23:13 ET
Allergic Asthma - Pipeline Review, H2 2013 (MTO)

2014-12-12@09:05:24 ET
AstraZeneca (AZN) Trading Near $74.41 Resistance Level (FBM)

2014-12-12@05:02:00 ET
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 (MTO)

2014-12-11@16:01:00 ET
Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1(TM) Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis (PRN)

2014-12-11@09:01:36 ET
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014 (MTO)

2014-12-11@07:52:07 ET
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014 (MTO)

2014-12-10@14:11:22 ET
Shares of AstraZeneca Are Moving Higher on 4.0x Above-Average Volume (AZN) (F82)

2014-12-10@12:49:39 ET
Potential AstraZeneca (AZN) Trade Has 5.83% Downside Protection (FBM)